ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,439Medicare Part D Prescriptions Filled, Including Refills

Rank: 261 out of 1121

$577K Total Retail Price of All Prescriptions

Rank: 312 out of 1121

377 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 528 328 1 2
HYDROCODONE-ACETAMINOPHEN 436 186 S3 2 3
SIMVASTATIN 419 315 3 1
AMLODIPINE BESYLATE 374 325 4 5
OMEPRAZOLE 370 231 5 6
FUROSEMIDE 323 256 6 7
ZOLPIDEM TARTRATE 253 165 7 19
LISINOPRIL 252 152 8 4
METOPROLOL TARTRATE 226 160 9 9
OXYCODONE HCL 224 31 S2 10 68
ATENOLOL 223 165 11 16
MORPHINE SULFATE ER 192 71 S2 12 87
MELOXICAM 185 148 13 22
CARISOPRODOL 175 0 R 14 72
PANTOPRAZOLE SODIUM 174 123 15 29
POTASSIUM CHLORIDE 173 127 16 12
METFORMIN HCL 170 91 17 8
GLIMEPIRIDE 164 108 18 34
GABAPENTIN 158 76 19 13
NEXIUM 140 76 20 24
PROAIR HFA 139 50 21 48
TRAMADOL HCL 138 96 22 25
CLOPIDOGREL 136 105 23 27
CITALOPRAM HBR 122 76 24 18
WARFARIN SODIUM 122 107 24 11
CRESTOR 118 83 26 28
PLAVIX 117 88 27 42
ATORVASTATIN CALCIUM 111 82 28 15
AZITHROMYCIN 106 76 29 44
BENAZEPRIL HCL 101 80 30 41
GLYBURIDE 98 62 R 31 51
FOSINOPRIL SODIUM 98 58 31 233
CLONIDINE HCL 92 56 33 39
PROMETHAZINE HCL 92 0 R 33 67
PRAVASTATIN SODIUM 87 48 35 14
HYDROCHLOROTHIAZIDE 86 66 36 10
HYDRALAZINE HCL 82 65 37 66
SYNTHROID 81 78 38 55
TRAZODONE HCL 69 52 39 40
ALLOPURINOL 67 53 40 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 44 41 31
ALENDRONATE SODIUM 62 49 42 37
LOSARTAN POTASSIUM 59 52 43 17
ZETIA 58 42 44 80
RANITIDINE HCL 57 37 45 33
LOVASTATIN 57 47 45 26
TIZANIDINE HCL 56 0 47 124
LYRICA 54 32 48 76
TAMSULOSIN HCL 54 41 48 32
METOPROLOL SUCCINATE 53 36 50 23
MECLIZINE HCL 52 38 51 115
FLUTICASONE PROPIONATE 52 30 51 36
OXYCODONE HCL-ACETAMINOPHEN 52 44 S2 51 86
SPIRONOLACTONE 50 29 54 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.